Stroke patient thankful for MSU
11 September 2023
It was Geoff’s young grandson who first noticed that something wasn’t quite right with his grandfather. After his family called triple zero (000), the Mobile Stroke Unit (MSU) was dispatched. (Photo: Herald Sun)The RMH neurologist receives $2 million to advance MND research and care
04 September 2023
The RMH neurologist and The Florey Institute researcher Dr Thanuja Dharmadasa has received funding for three grants in a record investment from FightMND.
Stroke patient reunited with lifesaving team
08 August 2023
This week is Stroke Week and in a heartfelt reunion, members from our Mobile Stroke Unit (MSU) team were reunited with stroke patient, Sebastian.
Studying effectiveness of AHSCT in highly active relapsing-remitting MS patients
28 July 2023
Researchers from the Royal Melbourne Hospital (RMH) have conducted a ground-breaking study comparing different treatment options for highly active relapsing-remitting multiple sclerosis (MS) patients who have shown limited response to conventional therapies.A hard act to swallow – how Greg bounced back from a stroke of misfortune
16 March 2023
Greg suffered a major stroke in late 2022, something he understatedly describes as an ‘interesting experience’.
New study finds thrombectomy benefits patients with large ischaemic strokes
13 February 2023
A recent study has shown that endovascular thrombectomy, a minimally invasive procedure that removes blood clots, can improve the outcomes of patients with large ischaemic strokes.Brain interface proves to be safe and effective
24 January 2023
A device the size of a small paperclip, created to give people with severe paralysis the ability to communicate again, has been shown to be safe.New study suggests acute stroke treatment is influenced by ethnicity and race
20 July 2022
An international, randomised controlled ischaemic stroke trial DIRECT-SAFE suggests acute stroke treatment should be adapted based on ethnicity and race.
Severity of MS linked to distance from the equator
03 June 2022
A large international study has found that the severity of multiple sclerosis (MS) can vary depending on latitude, with those living furthest from the equator worse affected by the disease.World-first clot-busting drug trial improves patient care on Mobile Stoke Unit
09 May 2022
A randomised controlled drug trial suggests clot-busting drug Tenecteplase provides better outcomes for stroke patients compared to the current standard of care alteplase.

Stay in touch with us
Sign up to our mailing list!
Keep informed of the latest happenings at the Royal Melbourne Hospital with our new monthly e-newsletter.

Media enquiries
We provide a media service from 6am to 10pm each day. Journalists are welcome to contact our media advisor on-call via the RMH Switchboard on (03) 9342 7000.
During business hours, journalists can email mh-communications@mh.org.au. We do not respond to emails outside business hours.